Uecker Darrin
- SEC CIK
- 0001276311
No open-market purchases or sales filed in the past year.
Current role at each company
- PLSE Pulse Biosciences, Inc.Chief Technology Officeras of Apr 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Uecker Darrin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2025 (view filing) | Sep 16-17 | 2 days | Uecker DarrinChief Technology Officer | SSale | −45.0K | $16.25 | −$731.2K | −26.8%122.9K after | 2 lots10b5-1 |
| Sep 15, 2025 (view filing) | Sep 11-15 | 4 days | Uecker DarrinChief Technology Officer | SSale | −75.0K | $14.96 | −$1.12M | −37.9%122.9K after | 3 lots10b5-1 |
| Jun 16, 2025 (view filing) | Jun 12-13 | 4 days | Uecker DarrinChief Technology Officer | SSale | −30.0K | $16.19 | −$485.7K | −19.6%122.9K after | 2 lots |
| Jun 10, 2022 (view filing) | Jun 9 | 1 day | Uecker DarrinDirector | PPurchase | +7.37K | – | – | –7.37K after | Derivative |